Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 35

Related Articles by Review for PubMed (Select 20565701)

1.

Invited commentary on low high-density lipoprotein is a risk for vascular disease.

Kiangkitiwan B, Haririan A.

Transpl Int. 2010 Jun;23(6):571-3. doi: 10.1111/j.1432-2277.2009.01036.x. No abstract available.

PMID:
20565701
2.

High-density lipoprotein cholesterol: current perspective for clinicians.

Whayne TF Jr.

Angiology. 2009 Oct-Nov;60(5):644-9. doi: 10.1177/0003319709331392. Epub 2009 Feb 23. Review.

PMID:
19240106
3.

The importance of recognizing and treating low levels of high-density lipoprotein cholesterol: a new era in atherosclerosis management.

Cardenas GA, Lavie CJ, Cardenas V, Milani RV, McCullough PA.

Rev Cardiovasc Med. 2008 Fall;9(4):239-58. Review.

PMID:
19122582
4.

Nicotinic acid, alone and in combinations, for reduction of cardiovascular risk.

Brown BG, Zhao XQ.

Am J Cardiol. 2008 Apr 17;101(8A):58B-62B. doi: 10.1016/j.amjcard.2008.02.039. Review.

PMID:
18375243
5.

Pharmacologic management of isolated low high-density lipoprotein syndrome.

Bermúdez V, Cano R, Cano C, Bermúdez F, Arraiz N, Acosta L, Finol F, Pabón MR, Amell A, Reyna N, Hidalgo J, Kendall P, Manuel V, Hernández R.

Am J Ther. 2008 Jul-Aug;15(4):377-88. doi: 10.1097/MJT.0b013e318169bc0b. Review.

PMID:
18645343
6.

Gene therapy in disorders of lipoprotein metabolism.

Vaessen SF, Twisk J, Kastelein JJ, Kuivenhoven JA.

Curr Gene Ther. 2007 Feb;7(1):35-47. Review.

PMID:
17305527
7.

Niacin-ER/statin combination for the treatment of dyslipidemia: focus on low high-density lipoprotein cholesterol.

Chrysant SG, Ibrahim M.

J Clin Hypertens (Greenwich). 2006 Jul;8(7):493-9; quiz 500-1. Review.

PMID:
16849903
8.
10.

High-density lipoproteins and cardiovascular disease: 2010 update.

Alwaili K, Awan Z, Alshahrani A, Genest J.

Expert Rev Cardiovasc Ther. 2010 Mar;8(3):413-23. doi: 10.1586/erc.10.4. Review.

PMID:
20222819
11.

Dyslipidemia in the metabolic syndrome in children.

Gidding SS.

J Cardiometab Syndr. 2006 Summer;1(4):282-5. Review.

PMID:
17679808
12.

When high is low: raising low levels of high-density lipoprotein cholesterol.

Toth PP.

Curr Cardiol Rep. 2008 Nov;10(6):488-96. Review.

PMID:
18950560
13.

Diabetic dyslipidemia: extending the target beyond LDL cholesterol.

Nicholls SJ, Lundman P, Tardif JC.

Eur J Cardiovasc Prev Rehabil. 2010 May;17 Suppl 1:S20-4. doi: 10.1097/01.hjr.0000368195.09485.17. Review.

PMID:
20489416
14.

Targeting high-density lipoprotein cholesterol in the management of cardiovascular disease.

Davidson MH.

Am Heart Hosp J. 2007 Fall;5(4):210-6. Review.

PMID:
17982304
15.

High-density lipoprotein as a therapeutic target: clinical evidence and treatment strategies.

Toth PP.

Am J Cardiol. 2005 Nov 7;96(9A):50K-58K; discussion 34K-35K. Epub 2005 Sep 15. Review.

PMID:
16291015
16.

Significance of high density lipoprotein-cholesterol in cardiovascular risk prevention: recommendations of the HDL Forum.

Ascaso JF, Fernández-Cruz A, González Santos P, Hernández Mijares A, Mangas Rojas A, Millán J, Felipe Pallardo L, Pedro-Botet J, Pérez-Jiménez F, Pía G, Pintó X, Plaza I, Rubiés-Prat J; HDL Forum.

Am J Cardiovasc Drugs. 2004;4(5):299-314. Review.

PMID:
15449972
17.
18.

Update on strategies to increase HDL quantity and function.

Duffy D, Rader DJ.

Nat Rev Cardiol. 2009 Jul;6(7):455-63. doi: 10.1038/nrcardio.2009.94. Epub 2009 Jun 2. Review.

PMID:
19488077
19.

Mixed dyslipidemia, metabolic syndrome, diabetes mellitus, and cardiovascular disease: clinical implications.

Cannon CP.

Am J Cardiol. 2008 Dec 22;102(12A):5L-9L. doi: 10.1016/j.amjcard.2008.09.067. Review.

PMID:
19084083
20.

Optimal therapy of low levels of high density lipoprotein-cholesterol.

Kashyap ML, Tavintharan S, Kamanna VS.

Am J Cardiovasc Drugs. 2003;3(1):53-65. Review.

PMID:
14727946
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk